Home
Resources
Follow portfolio news
...

Innovative company. Sierra Space joins forces with Redwire to produce drugs in space

Published on
13/9/2023
Amended on
6/11/2026
0
minute(s)
Odyssey 2021
spacecraft orbiting the earth
Sierra Space partners with Redwire to facilitate pharmaceutical research in space. Redwire will develop biotechnology facilities for Sierra Space's LIFE space platform, accelerating drug production. These advances promise more efficient and sustainable versions. Deliveries scheduled for Q4. Space microgravity projects attract many companies.
By
Damien Hélène
Damien Hélène
Innovative company. Sierra Space joins forces with Redwire to produce drugs in space
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

Sierra Space, a participant in the Odyssey Vintage Altaroc Odyssey , has just announced its partnership with the American aerospace manufacturer Redwire. Their goal? To facilitate the production of medications in space.

Redwire will create biotech facilities that will later be integrated into Sierra Space's space platform.

This equipment will accelerate pharmaceutical and biotechnological research as part of Sierra Space's Large Integrated Flexible Environment (LIFE) habitat project.

" We're going into space not only for science and discovery, but also to improve life on Earth," Mike Gold, Redwire's chief growth officer, told CNBC. " Many medicines are based on crystals. In space, you can create perfect, or at least different, crystals that can then be harnessed to create new versions of drugs with greater efficacy and the ability to last longer."

Plant development is underway, with delivery scheduled for the 4th quarter.

Biological and pharmaceutical research and production are extremely buoyant markets for microgravity platforms in space. Redwire is not the only company to position itself in this market. Varda and Space Forge are also stepping up their trials.

Sierra Space's LIFE project will be a central component of the Orbital Reef space station, which will replace the International Space Station(ISS) by the end of the decade. Orbital Reef will be designed as a "business park" in space, accommodating both astronauts for their research work and space tourists.

‍

Other content in this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
04
2026-11-04
News from the Vintage Altaroc Companies
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
22
2026-10-22
From elite sports to medical AI: what's new in the portfolio Altaroc
Follow portfolio news
From elite sports to medical AI: what's new in the portfolio Altaroc
Software adopted by every NFL team, AI agents that have already conducted 180 million interactions with patients, and a platform used by nearly one in five Fortune 500 companies. A look at nine acquisitions by the " Vintage "Odyssey over the past three months.
Article
|
19
2026-10-19
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
08
2026-10-08
A triptych illustrating the sports, health, and business sectors for corporate news from Vintage Altaroc
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
23
2026-09-23
Interview with Raul Villar, CEO of Optro
Follow portfolio news
Interview with Raul Villar, CEO of Optro
Raul Villar Jr. unveils his platform's global growth strategy, powered by AI, and his partnership with Hg
Video
|
13
2026-08-13
Interview with Chris Maclin, CEO of Empyrean
Follow portfolio news
Interview with Chris Maclin, CEO of Empyrean
In Boston, Chris Maclin, CEO of Empyrean, explains how his technology platform protects banks and modernizes risk management
Video
|
29
2026-05-29
Interview with Ian Drysdale, CEO of One Inc.
Follow portfolio news
Interview with Ian Drysdale, CEO of One Inc.
Learn about the career of Ian Drysdale, CEO of One Inc, a specialist in payment infrastructure for the insurance industry.
Video
|
09
2026-04-09
Interview with Daniel Baker, CEO of Healthdrive
Follow portfolio news
Interview with Daniel Baker, CEO of Healthdrive
In Boston, Daniel Baker, CEO of HealthDrive, shares his vision for sustainable growth with a human impact.
Video
|
29
2026-01-29
Interview Jeff Wessler - CEO Heartbeat
Follow portfolio news
Interview Jeff Wessler - CEO Heartbeat
Dr. Jeff Wessler, founder of Heartbeat Health, pioneer of virtual-first cardiology in the United States
Video
|
25
2025-11-25
Special report - Focus on the United States: 10 hypergrowth companies
Follow portfolio news
Special report - Focus on the United States: 10 hypergrowth companies
As the historic driving force behind global private equity, the United States is home to some of the most dynamic companies on the planet. This report highlights 10 hyper-growth American companies, backed by private equity, at the heart of key economic sectors.
File
|
12
2024-03-12
No articles in this category yet.
Welcome to Altaroc
In accordance with applicable regulations, we ask that you complete your profile. This step is required to access the content and services offered on our websites.
Please fill out your profile to access the site
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Select your language and investor profile to continue
Select your investor profile to continue
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.